HMG 75 IU

Human Menopausal Gonadotropin (HMG) is a gonadotropin preparation containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity. These glycoprotein hormones interact with their respective receptors, follicle-stimulating hormone receptor (FSHR) and luteinizing hormone/choriogonadotropin receptor (LHCGR), both of which belong to the G protein-coupled receptor (GPCR) superfamily. Activation of these receptors initiates Gsα-coupled signaling pathways, resulting in intracellular cAMP generation, protein kinase A (PKA) activation, and downstream signal transduction processes.

Experimental investigations have utilized HMG as a research tool for studying gonadotropin receptor pharmacology, receptor-ligand interactions, GPCR signaling mechanisms, receptor activation kinetics, and comparative analyses of FSHR and LHCGR-mediated pathways. Research applications include gonadotropin signaling studies, receptor characterization, signal transduction investigations, and mechanistic evaluation of glycoprotein hormone receptor biology.